The role of mitochondria in sepsis-induced cardiomyopathy.
Heart
Inflammation
Metabolism
Mitochondria
Organ failure
Sepsis
Journal
Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730
Informations de publication
Date de publication:
01 04 2019
01 04 2019
Historique:
received:
23
08
2018
revised:
02
10
2018
accepted:
05
10
2018
pubmed:
21
10
2018
medline:
30
11
2019
entrez:
21
10
2018
Statut:
ppublish
Résumé
Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. Myocardial dysfunction, often termed sepsis-induced cardiomyopathy, is a frequent complication and is associated with worse outcomes. Numerous mechanisms contribute to sepsis-induced cardiomyopathy and a growing body of evidence suggests that bioenergetic and metabolic derangements play a central role in its development; however, there are significant discrepancies in the literature, perhaps reflecting variability in the experimental models employed or in the host response to sepsis. The condition is characterised by lack of significant cell death, normal tissue oxygen levels and, in survivors, reversibility of organ dysfunction. The functional changes observed in cardiac tissue may represent an adaptive response to prolonged stress that limits cell death, improving the potential for recovery. In this review, we describe our current understanding of the pathophysiology underlying myocardial dysfunction in sepsis, with a focus on disrupted mitochondrial processes.
Identifiants
pubmed: 30342158
pii: S0925-4439(18)30388-0
doi: 10.1016/j.bbadis.2018.10.011
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
759-773Subventions
Organisme : Medical Research Council
ID : MR/N013867/1
Pays : United Kingdom
Informations de copyright
Copyright © 2018 Elsevier B.V. All rights reserved.